Health
Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant – CTV News
An internal safety report by pharmaceutical giant AstraZeneca describes how a participant in its vaccine trial developed trouble walking, weakness and pain in her arms, and other symptoms.
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later, AstraZeneca dismissed media reports about the participant havin…
-
Noosa News21 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General20 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News13 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News16 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards